DFIB Cardiac Science (MM)

Hagemeyer North America and Cardiac Science Partner to Sell AEDs and Training Services to Industrial Workplace Segment 350-person HNA U.S. Sales Force Serves Thousands of Industrial Clients IRVINE, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic public access defibrillators (AEDs), today announced it entered into a distribution partnership with Charleston, SC-based Hagemeyer North America, Inc., (HNA) a $1.6 billion division of Netherlands-based distribution giant Hagemeyer NV. Under the agreement, Cardiac Science Powerheart(R) AEDs and AED/CPR training and program management services will be marketed by Hagemeyer's 350-person sales force to its industrial and safety supplies customers throughout the United States. HNA is a business-to-business distributor of services and supplies focusing on the industrial, safety and electrical products. HNA serves local markets throughout the United States, Canada and Mexico and its more than 4,900 associates serve more than 100,000 customers in total. Raymond W. Cohen, Chairman and CEO of Cardiac Science said that the company is making a focused effort to ally itself with the very best industrial and safety products distributors in the marketplace. "Hagemeyer is a global leader in supplies and workplace safety distribution and their recent acquisitions indicate that they are firmly committed to building a dominant position in the U.S.," Cohen said. "This partnership is consistent with our strategy to maintain our leadership position in the U.S. workplace market by aligning ourselves with powerful strategic distribution partners that have established relationships in our target markets." Cohen added, "We are committed to putting high quality 'feet on the street' to sell our products and services and supporting them with our 55-person sales team. Similar to other recently announced partnerships, Cardiac Science representatives will work together with Hagemeyer sales personnel in a joint effort at point of sale to promote the adoption of workplace AED programs and the selection of Powerheart AEDs and Program Management Services by the customer." About Hagemeyer North America, Inc. HNA is a business-to-business distributor of services and products focusing on the industrial, safety and electrical markets. They have sites conveniently located to serve local markets throughout the United States, Canada and Mexico. Headquartered in Charleston, South Carolina, HNA has operations in Canada, Mexico, and the United States of America. HNA focuses on four primary business segments as follows: industrial, contractors, homeland security and Technical services. For more information on HNA visit http://www.hagemeyerna.com/. About Hagemeyer N.V. Hagemeyer was established in the former Dutch East Indies (now Indonesia) in 1900. It was initially a small family firm known as Hagemeijer & Co., founded by the Hagemeijer brothers, Anton and Johan. The company has grown from that trading house active in small regional markets to a specialist in distribution and services in global business-to-business markets. Today, Hagemeyer N.V. is headquartered in Naarden, Netherlands (near Amsterdam). The company has 22,000+ employees serving more than a million customers in 37 countries worldwide. For more information on the history of Hagemeyer N.V., visit http://www.hagemeyer.com/. About Cardiac Science Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automated public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The company makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information please visit http://www.cardiacscience.com/. This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to the Company's "competitive advantage" in the workplace AED market and the achievement of sales to the HNA customer base and any future and "meaningful" revenue based on the Distribution Agreement with HNA. Cardiac Science cautions that these statements are subject to substantial risks and uncertainties and are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements and should not be relied upon by investors when making an investment decision. Information on other factors is detailed in the Company's Form 10-K for the year ending December 31, 2003, subsequent quarterly filings, and other documents filed by the Company with the Securities and Exchange Commission. Contact: Matt Clawson (Investors), or Michael Gioffredi Len Hall (Media) Chief Marketing Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300 (949) 797-3800 DATASOURCE: Cardiac Science, Inc. CONTACT: Investors, Matt Clawson, , or Media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Michael Gioffredi, Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, Web site: http://www.hagemeyer.com/ Web site: http://www.hagemeyerna.com/ Web site: http://www.cardiacscience.com/

Copyright